[Evaluation of the evidence on the HeartMate II and HeartWare ventricular assist devices for the treatment of chronic end-stage heart failure]
Sas G, Boothroyd LJ, Guertin JR, Lambert LJ, Morin JE, Chakor H, Bogaty P
Record ID 32012000859
French
Authors' objectives:
The objectives of this evaluation are to:
1. synthesize, by means of a systematic review, the recent evidence (2008-2011) on HeartMate II® (HM II) and HeartWare® (HW), with regard to effectiveness, safety and economic considerations, according to initial indication (bridge to transplantation or permanent "destination" therapy) for patients with end-stage chronic heart failure; and
2. provide an overview, by means of a narrative review, of organizational and ethical issues in VAD use, including the process of patient selection.
Details
Project Status:
Completed
Year Published:
2012
URL for published report:
http://www.inesss.qc.ca/fileadmin/doc/INESSS/Rapports/Cardio/ETMIS2012_Vol8_No15.pdf
URL for additional information:
http://www.inesss.qc.ca/fileadmin/doc/INESSS/Rapports/Cardio/INESSS_Summary_VAD_EN.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Heart Failure
Contact
Organisation Name:
Institut national d'excellence en sante et en services sociaux
Contact Address:
L'Institut national d'excellence en sante et en services sociaux (INESSS) , 2021, avenue Union, bureau 10.083, Montreal, Quebec, Canada, H3A 2S9;Tel: 1+514-873-2563, Fax: 1+514-873-1369
Contact Name:
demande@inesss.qc.ca
Contact Email:
demande@inesss.qc.ca
Copyright:
L'Institut national d'excellence en sante et en services sociaux (INESSS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.